| Oaklawn Care & Rehabilitation Center | |
| 201 Oaklawn Avenue, Mankato, Minnesota 56001 | |
| (507) 388-2913 | |
| Name | Oaklawn Care & Rehabilitation Center |
|---|---|
| Location | 201 Oaklawn Avenue, Mankato, Minnesota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 70 |
| Occupancy Rate | 75.29% |
| Medicare ID (CCN) | 245517 |
| Legal Business Name | Oaklawn Health Care Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1578502894 |
| Organization Name | THRO COMPANY |
| Address | Oaklawn Health Care Center, 201 Oaklawn Avenue, Mankato, MN 56001 |
| Phone Number | 507-388-2913 |
News Archive
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that it has enrolled the first patient in its European Phase 2 clinical trial evaluating WF10 as a treatment for allergic rhinitis.
Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it will collaborate with a pharmaceutical company to evaluate Trovagene's proprietary, urine-based, cell-free DNA technology for the detection of certain epidermal growth factor receptor mutations associated with lung cancer.
When treating early-stage prostate cancer, intensity modulated radiation therapy (IMRT) spares the bladder significantly more from direct radiation when compared to 3-D conformal proton therapy (3D-CPT), but the amount of rectal sparing is similar with both treatments, according to a study released in the October issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
Particle beam radiation therapy, a technology used to treat several types of cancer, is considered by some clinicians to be better than traditional radiation, but there is limited evidence about its safety compared with other types of radiation therapy, according to a new comparative effectiveness report funded by HHS' Agency for Healthcare Research and Quality.
The Pediatric Interventional Cardiac Symposium (PICS) & Adult Interventional Cardiac Symposium (AICS) Lifetime Achievement Award for 2007 was recently presented to John P. Cheatham, MD, Co-Director of The Heart Center at Columbus Children's Hospital and Professor of Pediatrics & Internal Medicine at The Ohio State University College of Medicine.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that it has enrolled the first patient in its European Phase 2 clinical trial evaluating WF10 as a treatment for allergic rhinitis.
Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it will collaborate with a pharmaceutical company to evaluate Trovagene's proprietary, urine-based, cell-free DNA technology for the detection of certain epidermal growth factor receptor mutations associated with lung cancer.
When treating early-stage prostate cancer, intensity modulated radiation therapy (IMRT) spares the bladder significantly more from direct radiation when compared to 3-D conformal proton therapy (3D-CPT), but the amount of rectal sparing is similar with both treatments, according to a study released in the October issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
Particle beam radiation therapy, a technology used to treat several types of cancer, is considered by some clinicians to be better than traditional radiation, but there is limited evidence about its safety compared with other types of radiation therapy, according to a new comparative effectiveness report funded by HHS' Agency for Healthcare Research and Quality.
The Pediatric Interventional Cardiac Symposium (PICS) & Adult Interventional Cardiac Symposium (AICS) Lifetime Achievement Award for 2007 was recently presented to John P. Cheatham, MD, Co-Director of The Heart Center at Columbus Children's Hospital and Professor of Pediatrics & Internal Medicine at The Ohio State University College of Medicine.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $37225 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 8.92 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.23 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 51.09 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.97 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.36 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.64 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.98 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 8.7 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.91 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.71 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.11 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.86 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.99 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.81 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 85.11 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 92.33 | 82.93 |
News Archive
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that it has enrolled the first patient in its European Phase 2 clinical trial evaluating WF10 as a treatment for allergic rhinitis.
Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it will collaborate with a pharmaceutical company to evaluate Trovagene's proprietary, urine-based, cell-free DNA technology for the detection of certain epidermal growth factor receptor mutations associated with lung cancer.
When treating early-stage prostate cancer, intensity modulated radiation therapy (IMRT) spares the bladder significantly more from direct radiation when compared to 3-D conformal proton therapy (3D-CPT), but the amount of rectal sparing is similar with both treatments, according to a study released in the October issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
Particle beam radiation therapy, a technology used to treat several types of cancer, is considered by some clinicians to be better than traditional radiation, but there is limited evidence about its safety compared with other types of radiation therapy, according to a new comparative effectiveness report funded by HHS' Agency for Healthcare Research and Quality.
The Pediatric Interventional Cardiac Symposium (PICS) & Adult Interventional Cardiac Symposium (AICS) Lifetime Achievement Award for 2007 was recently presented to John P. Cheatham, MD, Co-Director of The Heart Center at Columbus Children's Hospital and Professor of Pediatrics & Internal Medicine at The Ohio State University College of Medicine.
› Verified 8 days ago
Hillcrest Care & Rehabilitation Center Location: 714 Southbend Avenue, Mankato, Minnesota 56001 Phone: (507) 387-3491 | |
Laurels Peak Care & Rehabilitation Center Location: 700 James Avenue, Mankato, Minnesota 56001 Phone: (507) 345-4631 | |
Oaklawn Care & Rehabilitation Center Location: 201 Oaklawn Avenue, Mankato, Minnesota 56001 Phone: (507) 388-2913 |